Invention Application
- Patent Title: HEPATITIS C VIRUS INHIBITORS
-
Application No.: US15749557Application Date: 2016-07-27
-
Publication No.: US20180221342A1Publication Date: 2018-08-09
- Inventor: David B. Frennesson , Piyasena Hewawasam , Omar D. Lopez , Van N. Nguyen , Mark G. Saulnier , Yong Tu , Alan Xiangdong Wang , Gan Wang , Ningning Xu , Roshan Yadavrao Nimje , Hasibur Rahaman , Samayamunthula Venkata Satya Arun Kumar Gupta , Nicholas A. Meanwell , Makonen Belema
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Priority: IN2415/DEL/2015 20150806
- International Application: PCT/US16/44158 WO 20160727
- Main IPC: A61K31/4178
- IPC: A61K31/4178 ; A61P31/14
Abstract:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
Information query
IPC分类:
